Brenda Staehle

Brenda Staehle is an accomplished professional with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as Senior Vice President & General Manager at SDIX, LLC since June 2011, Brenda has held notable leadership roles, including V.P. of R&D QA & Compliance at Shire Pharmaceuticals from March 2005 to January 2011 and Director/Senior Director of Clinical Compliance at Wyeth from March 2002 to March 2005. Brenda's career began at Merck, where from April 1984 to March 2002, responsibilities included manufacturing and clinical research. Brenda holds an MBA in Pharmaceutical Management from Saint Joseph's University and a BS in Biochemistry from Albright College.